Vivos Therapeutics, Inc. (VVOS) › Cost of RevenueVivos Therapeutics, Inc. (VVOS) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2023: $5.53M2024: $6.01M2025: $6.90M$6.90M2023Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$6.90M+14.8%2024$6.01M+8.7%2023$5.53M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share